Movement Alert｜West Pharmaceutical Falls 5.41% in Regular Trading, Giving Back Post-Earnings Gains Despite Strong Q2 Beat and Raised Guidance

Market Focus07-25

On July 24, West Pharmaceutical declined 5.41% in regular trading, trading at approximately $336.26/share, with turnover of $1.36 billion. The stock gave back most of its prior session gains in a classic sell-the-news pattern following a strong earnings report.

The company reported Q2 adjusted EPS of $2.37, beating the consensus estimate of $2.08 by nearly 14% and representing a 28.8% year-over-year increase from $1.84. Net sales came in at $872.3 million versus the $840 million estimate, driven by a 29.6% surge in HVP delivery device sales to $131.2 million. Management simultaneously raised full-year adjusted EPS guidance to $8.85-$9.05, well above the prior range of $8.40-$8.75 and the Street estimate of $8.62.

Despite the beat, the stock retraced after surging over 6% in pre-market trading the prior session. On the same day, Jefferies raised its target to $410 and Deutsche Bank lifted its target to $420, both maintaining Buy ratings, yet the positive catalysts failed to sustain momentum as investors locked in profits.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192246479?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-25 00:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192246479","market":"hk","top_or_hot":-1,"title":"Movement Alert｜West Pharmaceutical Falls 5.41% in Regular Trading, Giving Back Post-Earnings Gains Despite Strong Q2 Beat and Raised Guidance","media":"Market Focus","content":"<p><p>On July 24, West Pharmaceutical declined 5.41% in regular trading, trading at approximately $336.26/share, with turnover of $1.36 billion. The stock gave back most of its prior session gains in a classic sell-the-news pattern following a strong earnings report.</p><p>The company reported Q2 adjusted EPS of $2.37, beating the consensus estimate of $2.08 by nearly 14% and representing a 28.8% year-over-year increase from $1.84. Net sales came in at $872.3 million versus the $840 million estimate, driven by a 29.6% surge in HVP delivery device sales to $131.2 million. Management simultaneously raised full-year adjusted EPS guidance to $8.85-$9.05, well above the prior range of $8.40-$8.75 and the Street estimate of $8.62.</p><p>Despite the beat, the stock retraced after surging over 6% in pre-market trading the prior session. On the same day, Jefferies raised its target to $410 and Deutsche Bank lifted its target to $420, both maintaining Buy ratings, yet the positive catalysts failed to sustain momentum as investors locked in profits.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜West Pharmaceutical Falls 5.41% in Regular Trading, Giving Back Post-Earnings Gains Despite Strong Q2 Beat and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜West Pharmaceutical Falls 5.41% in Regular Trading, Giving Back Post-Earnings Gains Despite Strong Q2 Beat and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-25 00:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 24, West Pharmaceutical declined 5.41% in regular trading, trading at approximately $336.26/share, with turnover of $1.36 billion. The stock gave back most of its prior session gains in a classic sell-the-news pattern following a strong earnings report.</p><p>The company reported Q2 adjusted EPS of $2.37, beating the consensus estimate of $2.08 by nearly 14% and representing a 28.8% year-over-year increase from $1.84. Net sales came in at $872.3 million versus the $840 million estimate, driven by a 29.6% surge in HVP delivery device sales to $131.2 million. Management simultaneously raised full-year adjusted EPS guidance to $8.85-$9.05, well above the prior range of $8.40-$8.75 and the Street estimate of $8.62.</p><p>Despite the beat, the stock retraced after surging over 6% in pre-market trading the prior session. On the same day, Jefferies raised its target to $410 and Deutsche Bank lifted its target to $420, both maintaining Buy ratings, yet the positive catalysts failed to sustain momentum as investors locked in profits.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WST","symbol_name":"West Pharmaceutical Services Inc","start_time":0,"source_url":"","article_id":"1192246479","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192246479","pubTimestamp":1784908857,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 24, West Pharmaceutical declined 5.41% in regular trading, trading at approximately $336.26/share, with turnover of $1.36 billion. The stock gave back most of its prior session gains in a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WST":"West Pharmaceutical Services Inc"},"translate_title":"走势警报|西部制药在常规交易中下跌 5.41%，尽管第二季度表现强劲且指引上调，但财报后仍回升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WST":1},"content_text":"On July 24, West Pharmaceutical declined 5.41% in regular trading, trading at approximately $336.26/share, with turnover of $1.36 billion. The stock gave back most of its prior session gains in a classic sell-the-news pattern following a strong earnings report.The company reported Q2 adjusted EPS of $2.37, beating the consensus estimate of $2.08 by nearly 14% and representing a 28.8% year-over-year increase from $1.84. Net sales came in at $872.3 million versus the $840 million estimate, driven by a 29.6% surge in HVP delivery device sales to $131.2 million. Management simultaneously raised full-year adjusted EPS guidance to $8.85-$9.05, well above the prior range of $8.40-$8.75 and the Street estimate of $8.62.Despite the beat, the stock retraced after surging over 6% in pre-market trading the prior session. On the same day, Jefferies raised its target to $410 and Deutsche Bank lifted its target to $420, both maintaining Buy ratings, yet the positive catalysts failed to sustain momentum as investors locked in profits.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192246479","isCrawlerRequest":true}